Molly Elizabeth Droege (Molly E Droege, Molly Droege)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Severe Traumatic Brain Injury

Venous Thromboembolism

Top Venues

The Annals of pharmacotherapy

Healthcare (Basel, Switzerland)

Journal of thrombosis and thrombolysis

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

William Olin Blair, Mary Allison Ellis, Maria Fada, Austin Allen Wiggins, Rachel C Wolfe, Gourang P Patel, Kara K Brockhaus, Molly Elizabeth Droege, Laura M Ebbitt, Brian J Kramer, Eric Likar, Kerilyn Petrucci, Sapna Shah, Jerusha Taylor, Paula Bingham, Samuel Krabacher, Jin Hyung Moon, Monica Rogoz, Edson Jean-Jacques, Robert K Cleary, Ransome Eke, Rachelle Findley, Richard H Parrish, null null
Effect of Pharmacoprophylaxis on Postoperative Outcomes in Adult Elective Colorectal Surgery: A Multi-Center Retrospective Cohort Study within an Enhanced Recovery after Surgery Framework. Healthcare (Basel, Switzerland) 11 (23) (2023)
Sarah Schuman Harlan, Carolyn D Philpott, Shaun P Keegan, Molly Elizabeth Droege, Aniruddha S Karve, Brandon Foreman, Devin Wakefield, Eric W Mueller, Kiranpal Sangha, Laura B Ngwenya, Joshua D Courter, Pankaj Desai, Christopher Allen Droege
Pharmacokinetics of Levetiracetam Seizure Prophylaxis in Severe Traumatic Brain Injury. The Annals of pharmacotherapy (2023)
Paige Garber Bradshaw, Shaun Patrick Keegan, Molly Elizabeth Droege, Nicole Jade Harger Dykes, Neil Edward Ernst, Madeline Jane Foertsch, Amy Teres Makley, Eric William Mueller, Carolyn Dosen Philpott, Vasisht Srinivasan, Jessica Brooke Winter, Michael D Goodman, Christopher Allen Droege
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures. Pharmacotherapy 42 (10) (2022)
Christopher Francis Janowak, Bradley Robert Becker, Carolyn Dosen Philpott, Amy Teres Makley, Eric William Mueller, Christopher Allen Droege, Molly Elizabeth Droege
Retrospective Evaluation of Intrapleural Tissue Plasminogen Activator With or Without Dornase Alfa for the Treatment of Traumatic Retained Hemothorax: A 6-Year Experience. The Annals of pharmacotherapy (2022)
Molly Elizabeth Droege, Christopher Allen Droege, Carolyn Dosen Philpott, Megan Leslie Webb, Neil Edward Ernst, Krishna Athota, Devin Wakefield, Joseph Richard Dowd, Dina Gomaa, Bryce H R Robinson, Dennis Hanseman, Joel Elterman, Eric William Mueller
Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial. Journal of thrombosis and thrombolysis 52 (4) (2021)